Alkermes Plc (ALKS) Shares Outstanding 2006–TTM

Name: Alkermes Plc (ALKS) shares outstanding history 2006-TTM
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

DATA UPDATED 2026-08-02

Alkermes Plc annual shares outstanding for fiscal TTM was 167 million shares, a decrease of 1.2% from 169 million shares in fiscal 2025. All figures are reported results from public filings — no estimates or projections.

ALKS Annual Shares Outstanding

Shares Outstanding (annual)	TTM → 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Shares Outstanding (M)	167M	169M	169M	170M	164M	161M	159M	157M	155M	153M	151M	149M	145M	145M	137M	137M	96M	96M	95M	96M	103M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ALKS Quarterly Shares Outstanding

Shares Outstanding (quarterly)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Shares Outstanding (M)	167M	166M	169M	169M	168M	169M	167M	167M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Shares Outstanding at Comparable Companies

UTHR Shares Outstanding — United Therapeutics Corporation
NBIX Shares Outstanding — Neurocrine Biosciences Inc
ELAN Shares Outstanding — Elanco Animal Health
RDY Shares Outstanding — Dr. Reddy’s Laboratories Ltd ADR
HIMS Shares Outstanding — Hims Hers Health Inc

More ALKS metrics: Revenue · Gross Profit · Operating Income · Net Income · EPS · EBITDA · Free Cash Flow

All ALKS financial statements → Interactive ALKS charts →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.